Oscillococcinum® for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)

Oscillococcinum® for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)

Background: Upper respiratory tract infections (URTIs) are a major cause of exacerbations in patients with chronic obstructive pulmonary disease (COPD). We assessed the effectiveness of Oscillococcinum® in the protection from URTIs in patients with COPD who had been vaccinated against influenza infe...

Full description

Bibliographic Details
Main Authors: Hichem Aouina, Anis Bamri, Aurélien Vesin, Karine Danno, Eléonore Aubry, Cécile Faure, Naoual Boujedaini
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-07-01
Series:Drugs in Context
Subjects:
chronic obstructive pulmonary disease
chronic respiratory illness
exacerbations
homeopathy
influenza vaccination
oscillococcinum
upper respiratory tract infection
Online Access:https://www.drugsincontext.com/oscillococcinum-for-upper-respiratory-tract-infections-and-exacerbations-in-copd-an-observational-prospective-study-oxitunis

Internet

https://www.drugsincontext.com/oscillococcinum-for-upper-respiratory-tract-infections-and-exacerbations-in-copd-an-observational-prospective-study-oxitunis

Similar Items